Fierce Pharma April 29, 2024
Merck KGaA will shell out 300 million euros ($321 million) to build a new research center at the pharma giant’s headquarters in Darmstadt, Germany.
The 18,000-square-meter Advanced Research Center will investigate solutions for manufacturing antibodies, mRNA applications and additional products required for biotechnological production, the company said in an April 24 press release. The new center is expected to employ about 550 workers when it is completed in early 2027.
The new research center is part of the company’s Darmstadt expansion program, which is expected to reach 1.5 billion euros ($1.6 billion) by 2025.
“With this strategic investment, we are strengthening our company’s leading position in key technologies for the development and manufacture of novel medicines,” Belén Garijo, executive board...
Today's Sponsors
Today's Sponsor